Rallybio Corporation (RLYB)

Rallybio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	90.69	31.37	13.9	24.49	56.96	175.33
Short-Term Investments	-	23.36	51.61	85.44	112.04	-
Cash & Short-Term Investments	90.69	54.74	65.51	109.93	168.99	175.33
Cash Growth	52.89%	-16.45%	-40.41%	-34.95%	-3.62%	25.03%
Prepaid Expenses	1.36	0.63	0.64	0.74	1.55	1.84
Other Current Assets	2.72	5.89	1.69	4.12	8.95	3.7
Total Current Assets	94.77	61.25	67.84	114.79	179.5	180.87
Property, Plant & Equipment	-	0.2	0.27	0.59	0.91	0.51
Long-Term Investments	-	-	-	0.24	0.03	0.81
Other Long-Term Assets	0.81	0.81	-	-	-	-
Total Assets	95.58	62.26	68.11	115.62	180.44	182.19

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.01	0.13	0.28	0.98	1.11	0.6
Accrued Expenses	1.93	3.79	4.96	8.07	9.45	5.95
Current Portion of Leases	-	0.09	0.15	0.22	0.18	-
Current Unearned Revenue	-	0.21	0.85	-	-	-
Total Current Liabilities	3.28	4.22	6.24	9.26	10.74	6.55
Long-Term Leases	-	0.08	-	0.17	0.37	-
Long-Term Unearned Revenue	-	-	0.21	-	-	-
Other Long-Term Liabilities	-	-	-	-	-	0.03
Total Liabilities	3.28	4.31	6.45	9.44	11.12	6.58

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	361.63	359.93	354.6	341.41	330.21	269.63
Retained Earnings	-269.34	-302	-293.02	-235.25	-160.68	-94.03
Comprehensive Income & Other	-	0.02	0.07	0.02	-0.21	-
Total Common Equity	92.3	57.96	61.65	106.18	169.32	175.6
Shareholders' Equity	92.3	57.96	61.65	106.18	169.32	175.6
Total Liabilities & Equity	95.58	62.26	68.11	115.62	180.44	182.19

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	0.18	0.15	0.39	0.56	-
Net Cash (Debt)	90.69	54.56	65.36	109.54	168.44	175.33
Net Cash Growth	53.40%	-16.52%	-40.33%	-34.97%	-3.93%	25.03%
Net Cash Per Share	15.74	9.69	12.01	21.67	42.35	54.97
Filing Date Shares Outstanding	5.38	5.29	5.2	4.73	4.76	4.02
Total Common Shares Outstanding	5.33	5.28	5.19	4.73	4.73	4.02
Working Capital	91.49	57.03	61.6	105.53	168.75	174.32
Book Value Per Share	17.31	10.97	11.88	22.46	35.80	43.72
Tangible Book Value	92.3	57.96	61.65	106.18	169.32	175.6
Tangible Book Value Per Share	17.31	10.97	11.88	22.46	35.80	43.72
Machinery	-	0.27	0.34	0.34	0.33	0.31
Construction In Progress	-	-	-	-	-	0.01
Leasehold Improvements	-	0.15	0.34	0.34	0.34	0.32

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error